Clinical Trial Update: Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability and pharmacokinetics of BAT8006 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAT8006

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED